CV · CapsoVision, Inc
$6.99
+0.19 (+2.79%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company, having evaluated the extant facts and circumstances, concluded that the facts and circumstances raise substantial doubt about the Company's ability to continue as a going concern within one year after the date of issuance of these financial statements. While the Company raised approximately $14 million in gross proceeds resulting from the Private Placement described in Note 1. DESCRIPTION OF BUSINESS AND ORGANIZATIONAL STRUCTURE and further discussed in Note 9. COMMON STOCK, it is not probable that these funds are sufficient to fund expenditures necessary to achieve sales growth and innovation objectives. The Company intends to consummate additional capital raising activities, but there is no certainty as to such capital raising activities occurring at all, or occurring with sufficient timing or magnitude, sufficient to alleviate such substantial doubt.”View the 10-Q filed Aug 13, 2026
Market Cap
$349.83M
Shares
50.05M
Volume · Oct 23
320.24K
Avg daily vol (3M)
160.72K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$6.99
Open$6.72
Day$6.66–7.18
52W close$4.59–14.42
Avg vol 30d229K
Short int2.1M · 4.2% float · 5.4d
Short vol66%
Last earningsAug 13, 2026
DataJul 2025–Oct 2026
Filing10-Q · Aug 13
Up next
Next earnings call
Nov 12, 2026
Est · unconfirmed
· in 3 wks
filed Aug 13, 2026
call held Aug 13, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$13.89M
Trailing 12 months
Net income (TTM)
−$29.83M
Trailing 12 months
Revenue growth YoY
+9.9%
Year over year
Operating margin
-217.1%
Trailing 12 months
P / E (TTM)
2.2
Trailing earnings · reciprocal yield 45.5%
FCF yield
-8.0%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+2,078.6%
Year over year · more shares
Price change (1Y)
+42.4%
Trailing year
Short interest
4.2%
Latest settlement · 5.4 days to cover
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Strong Buy
Momentum
Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 19.5 · elevated
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
Golden cross
Price vs 200-day avg
+10%
above
Price vs 50-day avg
+10%
above
RSI (14)
61
neutral
MACD trend
Positive
52-week position
24%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+5%
trailing
6-month return
−1%
trailing
YTD return
−35%
this year
Relative strength
−7%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
Golden cross
50d $6 › 200d $6 — 50d above 200d
Institutional flow
Accumulating
8 of 49 funds reported for Sep 30 · net +1.2K sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
4.20% of float · ▲ +10.8% MoM · 5.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
49 holders — mid 1-yr range
Squeeze score
75
high risk · 0–100
Fundamentals
Revenue growth
+15%
Y/Y
Gross margin
53%
contracting
EPS growth
+90%
Y/Y
Free cash flow
$-23.0M
Quant / Vol
risk profile
Volatility
98%
annualized · 1-yr
Max drawdown
−68%
past year
ATR
4.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
Golden cross
Bullish
Price vs 200-day avg
+10%
Bullish
Price vs 50-day avg
+10%
Bullish
RSI (14)
61
Neutral
MACD trend
Positive
Bullish
52-week position
24%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
Golden cross
50d $6 › 200d $6 — 50d above 200d
Institutional flow
Accumulating
8 of 49 funds reported for Sep 30 · net +1.2K sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
4.20% of float · ▲ +10.8% MoM · 5.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
49 holders — mid 1-yr range
Price context
position in its 52-week range
Range low $5
Now $7 · 24%
Range high $14
vs 200-day avg +10%
vs 50-day avg +10%
50-day above 200-day golden cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Average selling price change | 3% | Q2 FY2026 | — |
| CapsoCam Plus used by patients | 176,000 | as of June 30, 2026 | — |
| Number of CapsoCam Plus capsules sold (year-over-year change) | 13% | Q2 FY2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CV
this stock
CapsoVision, Inc
|
$349.83M | -34.6% | +15.3% | — | 4.2% |
|
ABT
Abbott Laboratories
|
$180.63B | -17.2% | +5.7% | 33.6 | 0.8% |
|
MDT
Medtronic plc
|
$122.04B | -0.7% | +8.4% | 23.5 | 3.1% |
|
SYK
Stryker Corp
|
$117.81B | -12.6% | +11.2% | 31.8 | 1.5% |
|
BSX
Boston Scientific Corp
|
$66.22B | -52.1% | +12.5% | 18.5 | 2.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CV | +7.0% | +5.1% | -1.1% | +8.2% | -34.6% |
| SPY | -0.4% | -1.5% | +5.8% | -0.4% | +11.5% |
| vs SPY | +7.5% | +6.6% | -7.0% | +8.6% | -46.1% |